Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 143 results found. Search for [ Coronavirus drug remdesivir ]

Results 1 to 21 of 143
BusinessToday.In
July 6, 2020
Mylan has been licensed by Gilead for marketing the drug in 127 low- and middle-income countries, including India. The company will manufacture remdesivir at its injectables facilities in India


BusinessToday.In
July 4, 2020
The drug has been making headlines with many health experts across the world recommending it for treatment of COVID-19. Remdesivir was originally used to treat Ebola patients


Reuters
July 4, 2020
A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: The DCGI approved the vaccine candidate for human trials after Zydus Cadila's candidate was found to be safe. The company is likely to start enrolment of subjects soon


BusinessToday.In
July 2, 2020
Kerala State Drugs and Pharmaceuticals (KSDP) expects to start production of ventilators by July-end after getting approval from Kerala Government and ICMR


Reuters
July 2, 2020
BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people


BusinessToday.In
July 1, 2020
Remdesivir supply: US Department of Health and Human Services said it has secured 500,000 treatment courses of remdesivir for American hospitals through September


PTI
July 1, 2020
Fujifilm is conducting a clinical study on Avigan to treat COVID-19 patients in Japan and the United States and has been seeking to increase the drug's production by partnering with domestic and overseas companies


BusinessToday.In
June 30, 2020
In terms of subscriber market share for wireless services, Reliance Jio held 32.9 per cent, with Bharti Airtel at 28.35 per cent and Vodafone Idea at 28 per cent share as on February 29, 2020


BusinessToday.In
June 30, 2020
In the US, federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September


Associated Press
New Delhi, June 29, 2020
The 250,000 treatment courses that the company had donated to the US and other countries will run out in about a week, and the prices will apply to the drug after that


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


E Kumar Sharma
New Delhi, June 27, 2020
\"Remdesavir seems to be useful for those who are coping with the beginning part of the disease and dexamethasone is useful for those who have to deal with the disease in its later phase within the body\"


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus drug updates: The next batch of Hetero's Remdesivir will be sent to Kolkata, Lucknow, Patna, Indore, Bhopal, Bhubaneshwar, Ranchi, Kochi, Trivandrum, Vijayawada and Goa


Reuters
June 25, 2020
Even with no existing approved vaccines, CEPI is already getting manufacturing and supply chains lined up in a quest to ensure coronavirus vaccines are distributed equitably around the globe


Reuters
June 25, 2020
Cipla and Hetero are among a bevy of drugmakers which have licensing agreements with US-based Gilead Sciences Inc, the original manufacturer of remdesivir, to make and sell the drug in 127 low- and middle-income countries


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


BusinessToday.In
New Delhi, June 24, 2020
Coronavirus vaccine news: Researchers at Imperial College London have administered their coronavirus vaccine to the first healthy volunteer; South Africa has initiated clinical trials of the University of Oxford candidate


Reuters
June 23, 2020
Cipla and privately held Indian drugmaker Hetero Labs on Sunday gained approval to sell generic versions of remdesivir in the country. Hetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees


PAGES 1 OF 8  12345